Evidence map›Paper›PMID 37875873›Full record

SynthesisBMC musculoskeletal disorders2023

Unilateral biportal endoscopic transforaminal lumbar interbody fusion versus conventional interbody fusion for the treatment of degenerative lumbar spine disease: a systematic review and meta-analysis.

Qi Yu, Hui Gen Lu, Xue Kang Pan, Zhong Hai Shen, Peng Ren, Xu Qi Hu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC musculoskeletal disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qi YuBengbu Medical College, Bengbu, 233030, Anhui, China.
Hui Gen LuBengbu Medical College, Bengbu, 233030, Anhui, China.
Xue Kang PanDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314001, Zhejiang, China.
Zhong Hai ShenDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314001, Zhejiang, China.
Peng RenBengbu Medical College, Bengbu, 233030, Anhui, China.
Xu Qi HuDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314001, Zhejiang, China. jxhuxuqi@sina.com.
Bengbu Medical College · CNJiaxing University · CN

Funding

Zhejiang Medical and Health Plan No. 2020KY957Zhejiang Medical and Health Plan No. 2022KY1251
6 · The paper itself

Abstract

backgroundThis meta-analysis compares the efficacy of unilateral biportal endoscopic transforaminal lumbar interbody fusion (UBE-TLIF) to conventional interbody fusion in lumbar degenerative diseases (LDD).

methodsAn extensive literature search was conducted in PubMed, Web of Science, and the Cochrane Library. Research related to UBE-TLIF published up to November 2022 was reviewed. The relevant articles were selected based on inclusion and exclusion criteria, as well as an evaluation of the quality of the data extraction literature. Meta-analysis was performed using Review Manager 5.3 software.

resultsThis meta-analysis included six high-quality case-control trials (CCTs) involving 621 subjects. The clinical outcomes assessment showed no statistical differences in complication rates, fusion rates, leg pain VAS scores, or ODI scores. After UBE-TLIF, low back pain VAS scores were significantly improved with less intraoperative blood loss and a shorter hospital stay. A longer time was required for UBE-TLIF, however.

conclusionDespite the lack of sufficient high quality randomized controlled trials (RCTs) in this study, the results of this meta-analysis suggest that UBE-TLIF is more effective than open surgery in terms of length of stay, blood loss reduction during surgery, and improved low back pain after surgery. Nevertheless, the evidence will be supplemented in the future by more and better quality multicenter randomized controlled trials.

Indexed as

Low Back PainSpinal FusionEndoscopyHumansLumbar VertebraeMinimally Invasive Surgical ProceduresRandomized Controlled Trials as TopicRetrospective StudiesTreatment OutcomeEndoscopyLumbarLumbar interbody fusionMeta-analysisUnilateral biportal

Identifiers

PMID37875873
PMCPMC10594799
OpenAlexW4387894320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.